We herewith report a case of amyloid goiter secondary to Crohn's disease. 
Abstract.
We herewith report a case of amyloid goiter secondary to Crohn's disease. The patient had been diagnosed as having Crohn's disease at the age of 15, and underwent right hemicolectomy at age 20. When he was 26 years old he complained of swelling of the anterior neck. Both TSH and thyroid hormones were within the normal range, and anti-thyroglobulin and anti-microsomal antibodies were negative.
Only thyroglobulin was noticeably above the normal range. During the next year his goiter enlarged further and because he had a feeling of pressure he underwent total thyroidectomy. [5, 6] .
We recently saw a rare case of amyloid goiter that developed 11 years after the onset of Crohn's disease.
We herewith report the details of the patient's condition and add a discussion.
Case Report
In 1984 a 15-year-old boy was diagnosed as having Crohn's disease and was treated with salazosulfapyridine orally. In 1989 at age 20, since he developed abdominal pain and diarrhea and his barium study and colonoscopy findings did not improve, he underwent right hemicolectomy. After that operation, although symptoms often developed, they were controlled by salazosulfapyridine and prednizolone.
In June, 1995 at age 26, the patient was first seen at our clinic complaining of swelling of the anterior neck. His thyroid gland was enlarged, nodular, firm and nontender. The size of the right lobe was 9.0 x 4.0 cm and the left was 8. As to the main clinical manifestations of amyloidosis, 21 patients had kidney involvement, 3 had intestinal involvement, and one had heart and one had thyroid involvement.
Meyers et al. [8] reported that 29.4% of patients with Crohn's disease had renal amyloidosis at autopsy, but only 1 % were diagnosed during life. Most cases of secondary amyloidosis are discovered by proteinuria or nephrotic syndrome due to renal amyloidosis [9] . In our patient, when he was first seen at our clinic in 1995, his laboratory data showed hypoalbuminemia.
Since his blood urea nitrogen and creatinine were normal and urinary protein was slightly positive, renal biopsy was not performed. Although the presence of renal amyloidosis could not be ruled out at that time, he was thought to be undernourished due to malabsorption because he had undergone ileotomy and Crohn's disease still persisted in his ileum. The fact that he needed a larger than normal dosage of levothyroxine after total thyroidectomy, may be explainable by his malabsorption state. In the report by Greenstein et al. [7] , there were 5 patients (0.16%) with amyloid deposition in the thyroid gland at biopsy or autopsy, and only one among them having had a clinical manifestation. Although it was reported that amyloid deposition was found in 50% of primary amyloidosis and 80% of secondary amyloidosis in surgical specimens or at autopsy [4] , it is said to be comparatively rare for goiter and abnormal thyroid function to be found [2, 5] , but Kimura et al. [10] recently reported that abnormalities of the thyroid gland were seen with a higher incidence than in previous reports [5] . According to Kimura et al. [10] , goiter was found in 63% of patients with secondary amyloidosis, and various thyroid dysfunctions were found in 90% of patients with goiter, which included hypothyroidism, hyperthyroidism and transient thyrotoxicosis.
They reported that in all patients with goiter Tg was higher than normal with or without thyroid dysfunction.
It is likely that Tg may increase due to destruction of thyroid follicles by amyloid deposition.
In our patient, we first made a diagnosis of adenomatous goiter based upon US and CT findings. In a previously reported case of amyloid goiter which was complicated by fatty infiltration, the thyroid US showed a high echogenicity [11] . In turn, Fontan et al. [12] reported several cases of amyloid goiter in which cystic and solid lesions coexisted, which, on a morphological basis, can be reasonably diagnosed as adenomatous goiter similar to our case. In our patient, the existence of amyloid A protein in the thyroid was confirmed, and there were no neoplasms or other inflammatory diseases other than Crohn's disease. We therefore consider the patient as another rare case of amyloid goiter developed in Crohn's disease. The preexisting literature reported that thyroid involvement is rare as a clinical manifestation of secondary amyloidosis, but we learned from our experience with this patient that it may be advisable to examine the thyroid gland for goiter and to monitor thyroglobulin in addition to renal function, 
